AAAAAA
Results:
1-16
|
Results: 16
Authors:
VIERGUTZ S
CULSHAW K
SCHLANDER M
Citation: S. Viergutz et al., A COMPARISON OF THE COST-EFFECTIVENESS OF PANTOPRAZOLE IN TREATING PEPTIC-ULCER DISEASE IN 6 EUROPEAN COUNTRIES, Gastroenterology, 114(4), 1998, pp. 1326-1326
Authors:
VIERGUTZ S
CULSHAW K
GODON P
SCHLANDER M
Citation: S. Viergutz et al., COST-EFFECTIVENESS OF PANTOPRAZOLE IN PATIENTS WITH PEPTIC-ULCER DISEASE IN FRANCE, Gastroenterology, 114(4), 1998, pp. 1327-1327
Authors:
CULSHAW K
VIERQUTZ S
EDWARDS AM
SCHLANDER M
Citation: K. Culshaw et al., A DECISION-ANALYSIS COMPARING THE COST-EFFECTIVENESS OF PANTOPRAZOLE IN ENGLAND, Gut, 41, 1997, pp. 97-98
Authors:
VIERGUTZ S
CULSHAW K
NETTEL H
SCHLANDER M
Citation: S. Viergutz et al., COMPARATIVE-ANALYSIS OF THE COST-EFFECTIVENESS OF PANTOPRAZOLE, RANITIDINE AND OMEPRAZOLE IN AUSTRIA USING DECISION-ANALYSIS, Gut, 41, 1997, pp. 98-99
Authors:
CULSHAW K
VIERGUTZ S
STEEN H
SCHOOK E
SCHLANDER M
Citation: K. Culshaw et al., TREATMENT OF PEPTIC-ULCER DISEASE WITH PANTOPRAZOLE - A COST-EFFECTIVENESS ANALYSIS IN THE NETHERLANDS, Gut, 41, 1997, pp. 98-98
Authors:
CULSHAW K
VIERGUTZ S
RAMOS JM
SOTO J
SCHLANDER M
Citation: K. Culshaw et al., COST-EFFECTIVENESS OF PANTOPRAZOLE IN TREATING PEPTIC-ULCER DISEASE IN SPAIN, Gut, 41, 1997, pp. 98-98
Authors:
HAHN EG
BOSSECKERT H
DAMMANN HG
SCHLANDER M
Citation: Eg. Hahn et al., TOLERABILITY AND SAFETY PROFILE OF PANTOPRAZOLE BASED ON 100.134 PATIENTS - RESULTS OF A GERMAN POST MARKETING SURVEILLANCE (PMS) PROGRAM, Gastroenterology, 112(4), 1997, pp. 138-138
Authors:
HAHN EG
BOSSECKERT H
DAMMANN HG
KASSEL G
SCHLANDER M
Citation: Eg. Hahn et al., TOLERABILITY AND SAFETY PROFILE OF PANTOPRAZOLE BASED ON 71906 PATIENTS - RESULTS OF A GERMAN POST MARKETING SURVEILLANCE (PMS) PROGRAM, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 21-21
Authors:
SCHLANDER M
Citation: M. Schlander, PANTOPRAZOLE - PHARMACOKINETICS AND DRUG-INTERACTIONS IN MAN - PREFACE, International journal of clinical pharmacology and therapeutics, 34, 1996, pp. 1-1
Authors:
DAMMANN HG
HAHN EG
ADLER G
SCHLANDER M
Citation: Hg. Dammann et al., PANTOPRAZOLE IS MORE EFFECTIVE THAN FAMOTIDINE IN ACUTE GASTROESOPHAGEAL REFLUX DISEASE, Gastroenterology, 110(4), 1996, pp. 89-89
PANTOPRAZOLE PROVIDES FASTER HEALING AND PAIN RELIEF THAN FAMOTIDINE IN ACUTE DUODENAL-ULCER DISEASE
Authors:
HAHN EG
DAMMANN HG
ADLER G
SCHLANDER M
Citation: Eg. Hahn et al., PANTOPRAZOLE PROVIDES FASTER HEALING AND PAIN RELIEF THAN FAMOTIDINE IN ACUTE DUODENAL-ULCER DISEASE, Gastroenterology, 110(4), 1996, pp. 127-127
Authors:
SCHOLTEN T
ADLER G
BOSSECKERT H
DAMMANN HG
HAHN EG
VONKLEIST DH
SCHLANDER M
Citation: T. Scholten et al., CLINICAL TOLERABILITY OF PANTOPRAZOLE COMPARED TO H-2-ANTAGONISTS - RESULTS OF THE GERMAN PANTOPRAZOLE PHASE-IV PROGRAM, Gastroenterology, 110(4), 1996, pp. 254-254
Authors:
VIERGUTZ S
MALFERTHEINER P
GATZ G
SCHLANDER M
Citation: S. Viergutz et al., THE COST-EFFECTIVENESS OF HELICOBACTER-PYLORI ERADICATION WITH DUAL AND TRIPLE THERAPY, Gastroenterology, 110(4), 1996, pp. 286-286
Authors:
VONKLEIST DH
BOSSECKERT H
SCHOLTEN T
SCHLANDER M
Citation: Dh. Vonkleist et al., PANTOPRAZOLE VERSUS RANITIDINE IN ACID-RELATED DISEASE - RESULTS OF THE GERMAN PANTOPRAZOLE PHASE-IV PROGRAM, Gastroenterology, 110(4), 1996, pp. 288-288
Authors:
DEMERS HG
SCHLANDER M
Citation: Hg. Demers et M. Schlander, DOSE TITRATION OF LOW-MOLECULAR-WEIGHT HEPARIN IN PATIENTS UNDERGOINGCHRONIC-HEMODIALYSIS, Nieren- und Hochdruckkrankheiten, 22(4), 1993, pp. 172-176
Authors:
HANDGRETINGER R
KLINGEBIEL T
BADEN B
FALEYRAS C
SIEDNER R
WENDT S
DOPFER R
SCHLANDER M
NIETHAMMER D
Citation: R. Handgretinger et al., STEM-CELL MOBILIZATION, COLLECTION AND TRANSPLANTATION IN PATIENTS WITH PEDIATRIC TUMORS, Cancer research, therapy & control, 3(1), 1992, pp. 43-48
Risultati:
1-16
|